Model
Edge
Adial Pharmaceuticals, Inc.
ADIL
Filing Type
S-8
Filing Date
8/27/2026
Updated
8/28/26, 2:47 PM
Copy Ref
Filing
S-8
Earnings Release
Exhibits
S-8
Registration Statement for Securities to be Offered to Employees
EX-5.1
OPINION OF BLANK ROME LLP
EX-23.1
CONSENT OF MARCUM LLP, FORMER INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR ADIAL PHARMACEUTICALS, INC
EX-23.2
CONSENT OF CBIZ CPAS P.C., INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR ADIAL PHARMACEUTICALS, INC
EX-23.3
CONSENT OF CBIZ CPAS P.C., INDEPENDENT AUDITOR FOR AZORA THERAPEUTICS, INC
EX-99.1
AZORA THERAPEUTICS, INC. 2017 EQUITY INCENTIVE PLAN
EX-99.3
STOCK OPTION INDUCEMENT AWARD GRANT NOTICE AND AGREEMENT, DATED AUGUST 19, 2026, BETWEEN ADIAL PHARMACEUTICALS, INC. AND CELIA ECONOMIDES
EX-FILING FEES
FILING FEE TABLE
GRAPHIC
Graphic